Omeprazole and ranitidine in long-term treatment of duodenal ulcer: A double-blind comparison of length of time in remission

被引：0

作者：

De Rojas F.D. ^{[1
]}

Berenguer J. ^{[1
]}

Rodrigo L. ^{[1
]}

Aran-Suau R. ^{[1
]}

Castel Branco Da Silveira J. ^{[1
]}

Clerch L. ^{[1
]}

Aparicio P.G. ^{[1
]}

Caswell C. ^{[1
]}

机构：

[1] Schering-Plough, S.A., 28046 Madrid, Paseo de la Castellana

来源：

Digestive Diseases and Sciences | 1998年 / 43卷 / 9期

关键词：

Duodenal ulcer; Maintenance treatment; Omeprazole;

D O I：

10.1023/A:1018882425236

中图分类号：

学科分类号：

摘要：

In most patients duodenal ulcer is a chronic relapsing disease. If no active maintenance treatment or eradication therapy is given after healing, around 70-100% of patients have a relapse during the first year. We conducted a double-blind multicenter study in 472 patients with duodenal ulcer. They were treated with omeprazole 20 mg every morning for four or eight weeks and when healed were randomly allocated to maintenance treatment with either omeprazole 20 mg every morning or ranitidine 150 mg at bedtime for up to six months. The patients were assessed by endoscopy at monthly intervals until healing occurred. Thereafter scheduled endoscopy was carried out after 1, 3, and 6 months of maintenance treatment or immediately in the event of a suspected relapse. Healing status (intention to treat approach) was 87% at four weeks and 93% at eight weeks. At six months the estimated remission rate was 90% for omeprazole and 82% for ranitidine (P = 0.03, 95% CI 1-15%). The incidence of adverse events was similar during the two maintenance treatments. Treatment with omeprazole 20 mg every morning maintained significantly more patients in remission than treatment with ranitidine 150 mg at bedtime.

引用

页码：1964 / 1969

页数：5

共 23 条

[1]

Bigard M.A., Isal J.P., Galmiche J.P., Ebrard F., Bader J.P., Omeprazole versus cimetidine in short-term treatment of acute duodenal ulcer, Gastroenterol Clin Biol, 11, pp. 753-757, (1987)

[2]

McFarland R.J., Bateson M.C., Green J.R.B., Et al., Omeprazole 20 mg provides quicker symptom relief and duodenal ulcer healing than ranitidine 300 mg nocte, Gastroenterology, 98, pp. 278-283, (1990)

[3]

Pounder R.E., What is an intractable duodenal ulcer and how should it be managed?, Alimen Pharmacol Ther, 1, (1987)

[4]

Meyrick Thomas J., Misiewicz G., Histamine H<sub>2</sub>-receptor antagonists in the short- And long-term treatment of duodenal ulcer, Clin Gastroenterol, 13, 2, pp. 501-541, (1984)

[5]

Solcia E., Bordi C., Creutzfeldt W., Et al., Histopathological classification of nonantral gastric endocrine growths in man, Digestion, 41, pp. 185-200, (1988)

[6]

Lauritsen K., Andersen B.N., Laursen L.S., Et al., Weekend administration of omeprazole in the prevention of duodenal ulcer relapse: A double-blind comparative trial, Gastroenterology, 96, (1989)

[7]

Bianchi-Porro G., Boiling E., Barbara L., Et al., Maintenance treatment with omeprazole in the prevention of duodenal ulcer relapse: A double-blind comparative trial, Digestive Diseases Week, (1990)

[8]

Savarino V., Sandro Mela G., Zentilin P., Et al., Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy, Dig Dis Sci, 39, pp. 161-168, (1994)

[9]

Boyd E.J.S., Johnston D.A., Penston J.G., Wormsley K.G., Does maintenance therapy keep duodenal ulcers healed?, Lancet, 1, pp. 1324-1327, (1988)

[10]

Walsh J.H., Peterson W.L., The treatment of Helicobacter pylori infection in the management, N Engl J Med, 333, pp. 984-988, (1995)

← 1 2 3 →